Charles Scott J 4
4 · Aralez Pharmaceuticals Inc. · Filed Jul 28, 2017
Insider Transaction Report
Form 4
Charles Scott J
Chief Financial Officer
Transactions
- Sale
Common Shares, without par value
2017-07-28$1.25/sh−10,804$13,509→ 280,551 total
Footnotes (1)
- [F1]This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 29,000 restricted stock units, which vested on July 27, 2017. 7,284 of such restricted stock units were previously granted on July 27, 2015 and 21,716 of such restricted stock units were previously granted on February 12, 2016.